Search

everythinglearnresearchcommunity

for

Search:↓

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

Janus kinase inhibitors reduce inflammation markers in severe alopecia areata patients.

General anesthesia might be linked to certain types of hair loss, but more research is needed.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Alopecia areata may be linked to higher heart disease risk.

Androgenetic alopecia is the most common type of non-scarring hair loss, especially in young males, and early diagnosis and treatment are important.

Squaric acid dibutylester helps hair growth by increasing certain immune cells in the skin.

High CRP levels could indicate vitamin D deficiency in people with alopecia areata.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Lower vitamin D levels are linked to higher CRP levels in people with a type of hair loss called alopecia areata.

The man's hair turned white suddenly but returned to normal on its own in 6 months.

Videodermoscopy is effective for diagnosing different types of non-scarring hair loss.

An 11-year-old child with total hair loss may have a genetic autoimmune disease, and the outlook for hair regrowth is not good.

COVID-19 reinfection may trigger alopecia areata.

Inhibiting TYK2 can restore hair growth in alopecia areata.

Topical diphencyprone effectively treated a 9-year-old boy's alopecia areata with fewer side effects.

A girl with a rare genetic condition affecting hair and nails also developed a common type of hair loss, suggesting a possible genetic link.

The microbiome may be linked to hair loss and could be a target for new treatments.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

Women with certain types of hair loss may have low iron levels.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Blood vessel patterns in skin diseases relate to certain blood markers in systemic sclerosis but not in psoriasis or psoriatic arthritis, and may indicate circulation issues in alopecia.

The document concludes that proper diagnosis and treatment of nonscarring alopecias can improve quality of life and hair regrowth is possible as the hair follicle remains intact.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Genetic discoveries are leading to new treatments for alopecia areata.

Alopecia Areata causes significant structural and compositional changes in hair.